Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
By using this website, you accept that you have read and understood our  cookie policy and  privacy policy

Notifications

Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib

Bonazzi V. F, Kondrashova O, Smith D, Nones K, Sengal A. T, Ju R, Packer L. M, Koufariotis L. T, Kazakoff S. H, Davidson A. L, Ramarao-Milne P, Lakis V, Newell F, Rogers R, Davies C, Nicklin J, Garrett A, Chetty N, Perrin L, Pearson J. V, Patch A.-M, Waddell N, Pollock P.

DOI: doi:10.1101/2021.03.30.436914
Date of Release: 2021-03-31

Genomics

0
0
0
0
0

All comments

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No comments